SHARE:  
MONTHLY | October 2019
MACS offers consultation to primary care and specialty prescribers in addressing the needs of their patients with substance use disorders and chronic pain management.
1-855-337-MACS (6227) |  www.marylandMACS.org  |  tsommer@som.umaryland.edu
MACS celebrates 2 years!
October 16th is the two year anniversary of our phone line opening. Thank you for being a part of the MACS community. As we celebrate, we're excited to be launching an expanded array of services including technical assistance and Project ECHO TM . Stay tuned for updates via email, social media , and our website .
Upcoming events.
Half & Half MAT Waiver Trainings
Central Maryland
Wednesday, October 9 | 7:30 am - 12 pm
Presented by MACS Consultant, Christopher Welsh, MD
Free! 8 CMEs upon completion of live & online portion.

Only a few spots left, sign up soon!

Eastern Shore
Wednesday, November 6 | 7:30 am - 12:45 pm
Presented by MACS Consultant, Eric Weintraub, MD
Free! 8 CMEs upon completion of live & online portion.  Read more in the local news...

Webinar
 Maryland's Prescription Drug Monitoring Program: A Tool to Support the Treatment of Patients with Substance Use Disorders
Tuesday, October 15 | 12 - 1 pm
Presented by MACS Consultant, Yngvild Olsen, MD, MPH
This event is online and can be streamed from any computer or mobile device.
MACS team members will be tabling and presenting at the following events:
2019 NPAM CE Conference: Pharmacology Focus
Saturday, October 12 | 7 am - 5 pm
JHU MAT Waiver Training
Saturday, October 19, 2019 | 8 am - 5 pm
2019 Maryland Rural Health Conference
October 21 - 22, 2019 | 7 am - 5 pm
MD/DC Society of Addiction Medicine Conference
Saturday October 26, 2019 | 7:30 am - 3 pm
News.
HOLIDAYS | The MACS line will be closed:
October 14 - Columbus Day
November 11 - Veteran's Day
November 28-29 - Thanksgiving
December 25 - Christmas Day
January 1 - New Year's Day
October Addiction Treatment & Prevention Campaigns
Resources.
Treatment Improvement Protocol (TIP) 63:
Medications for Opioid Use Disorder
This SAMHSA document reviews the use of the three FDA-approved medications used to treat opioid use disorder and the other strategies and services needed to support recovery for people with OUD.